Roles of exosomes in immunotherapy for solid cancers

Cong Lyu,Haifeng Sun,Zhenqiang Sun,Yang Liu,Qiming Wang

DOI: https://doi.org/10.1038/s41419-024-06494-z

2024-02-02

Cell Death and Disease

Abstract:Although immunotherapy has made breakthrough progress, its efficacy in solid tumours remains unsatisfactory. Exosomes are the main type of extracellular vesicles that can deliver various intracellular molecules to adjacent or distant cells and organs, mediating various biological functions. Studies have found that exosomes can both activate the immune system and inhibit the immune system. The antigen and major histocompatibility complex (MHC) carried in exosomes make it possible to develop them as anticancer vaccines. Exosomes derived from blood, urine, saliva and cerebrospinal fluid can be used as ideal biomarkers in cancer diagnosis and prognosis. In recent years, exosome-based therapy has made great progress in the fields of drug transportation and immunotherapy. Here, we review the composition and sources of exosomes in the solid cancer immune microenvironment and further elaborate on the potential mechanisms and pathways by which exosomes influence immunotherapy for solid cancers. Moreover, we summarize the potential clinical application prospects of engineered exosomes and exosome vaccines in immunotherapy for solid cancers. Eventually, these findings may open up avenues for determining the potential of exosomes for diagnosis, treatment, and prognosis in solid cancer immunotherapy.

cell biology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the role of exosomes and their potential mechanisms in the immunotherapy of solid tumors. Although immunotherapy has made significant progress in cancer treatment, its efficacy in solid tumors is still not satisfactory. As the main type of extracellular vesicles, exosomes can deliver various intracellular molecules to neighboring or distal cells and organs and mediate multiple biological functions. Studies have shown that exosomes can both activate and inhibit the immune system. The antigens and major histocompatibility complex (MHC) carried by exosomes make it possible to be developed into anti - cancer vaccines. In addition, exosomes from blood, urine, saliva and cerebrospinal fluid can be ideal biomarkers for cancer diagnosis and prognosis. In recent years, exosome - based therapies have made remarkable progress in the fields of drug delivery and immunotherapy.

The main objectives of the paper are:
1. **Summarize the composition and sources of exosomes in the immune microenvironment of solid tumors**.
2. **Elaborate in detail the potential mechanisms and pathways by which exosomes affect the immunotherapy of solid tumors**.
3. **Describe the potential clinical application prospects of engineered exosomes and exosome vaccines in the immunotherapy of solid tumors**.

Through these studies, the author hopes to open up new avenues for determining the diagnostic, therapeutic and prognostic potential of exosomes in the immunotherapy of solid tumors.